Long-term effectiveness and safety of nabiximols (tetrahydrocannabinol/cannabidiol oromucosal spray) in clinical practice.

Flachenecker, Peter; Henze, Thomas; K Zettl, Uwe

doi:10.1159/000360285

Public

Long-term effectiveness and safety of nabiximols (tetrahydrocannabinol/cannabidiol oromucosal spray) in clinical practice.

Shared by NobleBlocks on Jan 1, 2014 • 12:00 AM UTC

Authors:

Peter Flachenecker

Thomas Henze

Uwe K Zettl

Abstract

BACKGROUND: Nabiximols (Sativex®), in a cannabinoid-based oromucosal spray, is an add-on therapy option for patients with moderate to severe multiple sclerosis spasticity (MSS) resistant to other medications. The study objective was to provide long-term data on clinical outcomes, tolerability, quali...

Discussions